References
- Kuo G, Choo Q L, Alter H J, Gitnick G L, Redeker A G, Purcell R H, Miyamura T, Dienstag J L, Alter M J, Stevens C E, Tegtmeier G E, Bonino F, Colombo M, Lee W S, Kuo C, Berger K, Shuster J R, Overby L R, Bradley D W, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–364
- Alter H J, Purcell R H, Shih J W, Melpolder J C, Houghton M, Choo Q L, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–1500
- van der Poel C L, Reesink H W, Schaasberg W, Leentvaar-Kuypers A, Bakker E, Exel-Oehlers P J, Lelie P N. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 1990; 335: 558–560
- Esteban J I, Viladomiu L, Gonzaléz A, Roget M, Genesca J, Esteban R, López-Talavera J C, Hernández J M, Vargas V, Buti M, Guardia J, Houghton M, Choo Q L, Kuo G. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–297
- Mattsson L, Åberg B, Weiland O, Sellman M, Davilén J. Non-A, non-B hepatitis after open-heart surgery in Stockholm: Declining incidence after introduction of restrictions for blood donations due to the human immunodeficiency virus. Scand J Infect Dis 1988; 20: 371–376
- Mattsson L, Grillner L, von Sydow M, Bergdahl S, Weiland O. Seroconversion to hepatitis C virus in patients with acute posttransfusion non-A, non-B hepatitis in Sweden. Infection 1991; 19: 309–312
- Mattsson L, Gutierrez R A, Dawson G J, Lesniewski R R, Mushahwar I K, Weiland O. Antibodies to recombinant and synthetic peptides derived from the hepatitis C virus genome in long-term followed patients with posttransfusion hepatitis C. Scand J Gastroenterol 1991; 26: 1257–1262
- Grillner L, Bergdahl S, Jyrälä A. Non-A, non-B hepatitis after open-heart surgery in Sweden. Scand J Infect Dis 1982; 14: 171–175
- Siegel S, Castellan N, Jr. Nonparametric statistics for the behavioral sciences. McGraw-Hill Book Company. 1988; 128–137
- Krogsgaard K, Wantzin P, Mathiesen L R, Sonne J, Ring-Larsen H. The Copenhagen Hepatitis Acuta Programme. Early appearance of antibodies to hepatitis C virus in community acquired acute non-A, non-B hepatitis is associated with progression to chronic liver disease. Scand J Infect Dis 1990; 22: 399–402
- van der Poel C L, Reesink H W, Lelie P N, Leentvaar-Kuypers A, Choo Q L, Kuo G, Houghton M. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 1989; 2: 297–298
- Tanaka E, Kiyosawa K, Sodeyama T, Nakano Y, Shimizu S, Seki T, Furuta S, Kameko M. Anti-HCV and long-term prognosis in patients with non-A, non-B post-transfusion hepatitis. Jpn J Gastroenterol 1990; 87: 1003–1009
- Bradley D W, Maynard J E, Popper H, Cook E H, Ebert J W, McCaustland K A, Schable C A, Fields H A. Posttransfusion non-A, non-B hepatitis: physiochemical properties of two distinct agents. J Infect Dis 1983; 148: 254–265
- van der Poel C L, Cuypers H TM, Reesink H W, Weiner A J, Quan S, di Nello R, van Boven J JP, Winkel I, Mulder-Folkerts D, Exel-Oehlers P J, Schaasberg W, Leentvaar-Kuypers A, Polito A, Houghton M, Lelie P N. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317–319
- Ebeling F, Naukkarinen R, Myllylä G, Leikola J. Second generation RIBA to confirm diagnosis of HCV infection. Lancet 1991; 337: 912–913